Enhanced dissolution and bioavailability of raloxifene hydrochloride by co-grinding with different superdisintegrants

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 3, 2010, Pages 293-300

  Jagadish, Balasubramaniam ^a   Yelchuri, Rajesh ^a   Bindu, K ^a   Tangi, Hemalatha ^a   Maroju, Swetha ^a   Rao, Vinay Umesh ^b  

^a International Specialty Products India Pvt Limited   (India)

^b Daewoong Pharmaceutical Co Ltd   (India)

Author keywords

Co grinding; Crospovidone; Raloxifene HCl

Indexed keywords

CROSCARMELLOSE SODIUM; CROSPOVIDONE; RALOXIFENE; STARCH GLYCOLATE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DARK AGOUTI RAT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STRUCTURE; FEMALE; GRINDING; NONHUMAN; PARTICLE SIZE; RAT; SOLID STATE; X RAY DIFFRACTION;

ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CARBOXYMETHYLCELLULOSE; CHEMISTRY, PHARMACEUTICAL; FEMALE; PARTICLE SIZE; POVIDONE; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STARCH; SURFACE PROPERTIES; TEMPERATURE; TISSUE DISTRIBUTION; X-RAY DIFFRACTION;

EID: 77649266090     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.293     Document Type: Article

References (26)

1. Kerry J. H., Gordon N. A., Steven W. B., Ross A. J., Wayne D. L., Neil G. P., Eugene C. R., Cheryl A. T., Paul K. S. T., Robert E. W., Pharm. Dev. Technol., 5, 303-310 (2000).
2. Delmas P. D., Bjarnason N. H., Mitlak B., Ravoux A. C., Shah A., Huster W., Draper M., Christiansen C., N. Engl. J. Med., 337, 1641-1647 (1997).
3. Mitlak B. H., Cohen F. J., Horm. Res., 1997, 48155-48163 (1997).
4. Garg A., Singh S., Rao V. U., Bindu K., Balasubramaniam J., Drug Dev. Ind. Pharm., 35, 455-470 (2009).
5. Chaumeil J. C., Exp. Clin. Pharmacol., 20, 211-215 (1998).
6. Otsuka M., Kaneniwa N., Chem. Pharm. Bull., 32, 1071-1079 (1984).
7. Friedrich H., Nada A., Bodmeier R., Drug Dev. Ind. Pharm., 31, 719-728 (2005).
8. Sugimoto M., Okagaki T., Narisawa S., Koide Y., Nakajima K., Int. J. Pharm., 160, 11-19 (1998).
9. Suzuki H., Ogawa M., Hironaka K., Ito K., Sunada H., Drug Dev. Ind. Pharm., 27, 943-949 (2001).
10. Ahuja N., Katare O. P., Singh B., Eur. J. Pharm. Biopharm., 65, 26-38 (2007).
11. Mura P., Cirri M., Faucci M. T., Gines-Dorado J. M., Bettinetti G. P., J. Pharm. Biomed. Anal., 30, 227-237 (2002).
12. Takahashi Y., Nakashima T., Ishihara K., Nakagawa H., Sugimoto I., Drug Dev. Ind. Pharm., 11, 1543-1549 (1985).
13. Miyamae A., Kema H., Kawabata T., Yasuda T., Otsuka M., Matsuda Y., Drug Dev. Ind. Pharm., 20, 2881-2887 (1994).
14. Yamamoto K., Nakano M., Arita T., Takayama Y., Nakai Y., J. Pharm. Sci., 65, 1484-1488 (1976).
15. Kubo H., Osawa T., Takashima K., Mizobe M., Biol. Pharm. Bull., 19, 741-747 (1996).
16. Liversidge G. G., Cundy K. C., Int. J. Pharm., 125, 91-97 (1995).
17. Balasubramaniam J., Bindu K., Rao V. U., Ray D., Haldar R., Brzeczko A. W., Dissol. Technol., 2008, 18-25 (2008).
18. De Villiers M. M., Tiedt L. R., Pharmazie, 51, 564-567 (1996).
19. Hancock B. C., Zografi G., J. Pharm. Sci., 86, 1-12 (1997).
20. Williams A. C., Timmins P., Lu M., Forbes R. T., Eur. J. Pharm. Sci., 26, 288-294 (2005).
21. Betageri G. V., Makarla K. R., Int. J. Pharm., 126, 155-160 (1995).
22. Valizadeh H., Nokhodchi A., Qarakhani N., Zakeri-Milani P., Azarmi S., Hassanzadeh D., Lobenberg R., Drug Dev. Ind. Pharm., 30, 303-317 (2004).
23. Vippangunta S. R., Maul K. A., Tallavajhala S., Grant D. J. W., Int. J. Pharm., 236, 111-126 (2002).
24. Balasubramaniam J., Tim B., Pharm. Tech., 2009, s2-s9 (2009).
25. Augsburger L. L., Zhao N. A., AAPS PharmSciTech, 6, E634-E640 (2005).
26. International Specialty Products (ISP). Crospovidone, 2006: 〈Website: http://www.ispcorp.com/products/Pharma/content/brouchure/ polycros〉 Accessed August 16.